by BSPGHAN | Dec 20, 2021 | News
Dear members
I would like to personally thank the PGHAN Audit Steering Group, co chaired by John Fell and Ed Gaynor, Calvin Down from the RCPCH and all colleagues across the UK who have put time and effort into collecting and submitting information for the audit. This work continued to completion during the incredibly challenging circumstances of the COVID-19 pandemic.
This report, published jointly by The British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) and the RCPCH, highlights the main findings and recommendations identified through an audit of the provision of paediatric gastroenterology, hepatology and nutrition services for infants, children and young people with a wide range of conditions across the UK. Its recommendations offer healthcare professionals and providers expert guidance to drive improvement where needed.
The News page is here :https://www.rcpch.ac.uk/news-events/news/paediatricians-launch-landmark-report-gastrointestinal-liver-nutritional-disorders
Download your copy of The PGHAN/Audit report
Download Summaryof the PGHAN/ Audit report
Also see tweets https://twitter.com/RCPCHtweets/status/1471489611054551041
Sue Protheroe
BSPGHAN President 2019 – 2022
by BSPGHAN | Aug 22, 2021 | News
Dear members
Please see updated Guidance from the JCVI
https://www.gov.uk/government/publications/jcvi-statement-august-2021-covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years
in addition to previous advice
https://www.gov.uk/government/publications/covid-19-vaccination-of-children-and-young-people-aged-12-to-17-years-jcvi-statement
At this time,
- the Pfizer-BioNTech BNT162b2 vaccine is the only vaccine authorised for persons aged 12 to 17 years in the UK
- JCVI advises that all 16 to 17-year-olds should be offered a first dose of Pfizer-BNT162b2 vaccine.
- Persons aged 12 to 15 years with specific underlying health conditions that put them at risk of severe COVID-19, should be offered 2 doses of Pfizer-BNT162b2 vaccine with an interval of 8 weeks between doses.
This currently includes children with severe neuro-disabilities, Down’s Syndrome, underlying conditions resulting in immunosuppression, profound and multiple learning disabilities (PMLD), severe learning disabilities or who are on the learning disability register. Details regarding additional person-groups with underlying health conditions to be offered vaccination will be provided as updates in the Green Book.
Children and young people aged 12 years and over who are household contacts of persons (adults or children) who are immunosuppressed should be offered 2 doses of Pfizer-BNT162b2 vaccine.
The rollout of Covid vaccination in England will be led through primary care. The letter notes: “We recognise that not all eligible 12-15 year olds may be identified through the GP record. Therefore, any approach by parents of children at increased risk should be considered and clinical judgement used around eligibility in line with JCVI advice. In addition, trusts may refer 12-15 year olds for a COVID-19 vaccination if they consider them to be eligible”
Letter to primary care –
https://www.england.nhs.uk/coronavirus/publication/covid-19-vaccination-programme-actions-for-all-practices-to-support-vaccinating-eligible-12-15-year-olds/
FAQs on Vaccination delivery operations
https://www.england.nhs.uk/coronavirus/publication/vaccinating-children-and-young-people-faq
Best wishes
Sue
Dr S Protheroe
BSPGHAN President
by BSPGHAN | Jun 4, 2021 | News
The College has recently updated its webpage on the COVID-19 vaccine programme with some FAQs. This is available alongside advice for paediatricians published earlier this year on the eligibility of children and young people for COVID-19 vaccines in phase 1 of the programme. We’re continuing to monitor these issues and will update the FAQ page as the situation develops.
With best wishes,
Kate
Kate Webb
Health Policy Lead
Royal College of Paediatrics and Child Health
by BSPGHAN | May 10, 2021 | IBD, News
Dear Members
IBD UK will be sharing this open letter to Matt Hancock on the IBD UK website and Crohn’s & Colitis UK website on Monday morning. We will then be sharing it on social media channels with the attached graphic and copy below, which you are welcome to use in your own posts if you are planning on sharing the letter.
Twitter:
The @IBDUKTEAM report showed that IBD care across the UK needs to change. IBD needs to be taken seriously, so we’re asking @MattHancock for a clear government strategy for improvement. Please RT and support our ask for #BetterIBDCare https://ibduk.org/blog/2021/our-open-letter-to-matt-hancock
Facebook:
The IBD UK report showed that IBD care across the UK needs to change. IBD needs to be taken seriously, so we’re asking @matthancockofficial for a clear government strategy for improvement. Please share and support our ask for #BetterIBDCare https://ibduk.org/blog/2021/our-open-letter-to-matt-hancock
Best wishes.
Jackie
IBD UK
Crohn’s and Colitis UK acting as Secretariat to IBD UK
Tel No: 01727 734471
Email: info@ibduk.org
Follow us on Twitter: @IBDUKTEAM